Product Details

Verizy-S Suspension meets pharmacopoeial standards for the treatment of bacterial infections. Specifically, each 5ml delivers Azithromycin IP (as dihydrate) at 200mg. As a result, it offers effective, short-course macrolide antibiotic therapy in a convenient liquid formulation suited to children and adults.

The suspension contains:

• Azithromycin IP (as dihydrate, 200mg per 5ml) – A macrolide antibiotic that inhibits bacterial protein synthesis by binding to the 50S ribosomal subunit. Consequently, it exerts bacteriostatic and, at higher concentrations, bactericidal activity against a broad range of gram-positive, gram-negative, and atypical organisms.

Physicians prescribe Verizy-S for the treatment of respiratory tract infections, ear, nose, and throat infections, skin and soft tissue infections, and certain sexually transmitted infections. In addition, its short, once-daily dosing course supports high patient compliance, and its oral suspension format makes it especially suitable for children. Because of this profile, Verizy-S suits paediatric practices, general practice, and hospital settings managing common bacterial infections.

Key Features:

• Overall, this formulation guarantees pharmaceutical-grade purity
• Additionally, the oral suspension format supports easy, convenient dosing for children
• Furthermore, each 5ml delivers precise, validated dosage accuracy at 200mg
• Notably, rigorous quality testing backs every stage of manufacturing
• Beyond that, amber bottle packaging protects the light-sensitive formulation
• Ultimately, a reliable supply chain suits bulk distribution to hospitals, clinics, and pharmacies